Gel-E, the medical news and health industry reporting site, has joined VAGA. The reporting team from Gel-E will now write for and publish on Vagarights.com exclusively.
The move brings together teams with decades of experience in the fields of mental health, nootropics, and medical innovation. By combining these teams, VAGA hopes to be able to improve the quality of their research and content production in all areas from cognitive enhancement and biohacking to medical technology news and therapy development.
GEL-E began as a biotechnology company developing an advanced wound healing platform capable of being used across varied clinical and non-clinical settings. The company grew into a mature biotechnology company and a leading source of medical industry news.
According to Brian Johnson, Editor of Vagarights.com, the move is the latest in a string of acquisitons by the VAGA brand. He said: “Working with GEL-E is a really exciting development and will allow us to produce informative content on many moe areas of the biohacking world. Their expertise in the medical industry is extensive and that will show in what we are able to produce.”
Check out some of the pages published by GEL-E team members on Vagarights:
- Alpha Brain vs Mind Lab Pro
- Phosphatidylserine side effects
- Cycling nootropics
- Uridine monophosphate
- Modafinil and anxiety
- Noopept stack
- Nootropics for adrenal fatigue
- SAMe and depression